TickerFactsScreenerDevelopers

SELLAS Life Sciences Group, Inc. (SLS) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2010: $2.43M2011: $10.11M2012: $27.76M2013: $5.89M2014: $37.06M2015: -$12.26M2016: -$5.00M2017: $2.07M2018: $5.25M2019: $6.09M2020: $27.96M2021: $20.35M2022: $4.85M2023: -$7.98M2024: $9.46M2025: $70.87M$70.87M
2010Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$70.87M+648.8%
2024$9.46M+218.7%
2023-$7.98M-264.4%
2022$4.85M-76.2%
2021$20.35M-27.2%
2020$27.96M+358.9%
2019$6.09M+16.2%
2018$5.25M+153.4%
2017$2.07M+141.4%
2016-$5.00M+59.2%
2015-$12.26M-133.1%
2014$37.06M+529.6%
2013$5.89M-78.8%
2012$27.76M+174.5%
2011$10.11M+316.1%
2010$2.43M—